Acabas de hacer clic en un enlace para ir a otro sitio web. Si continúas, es posible que vayas a un sitio que no nos pertenece.
Nosotros no revisamos ni controlamos el contenido de los sitios que no son de Medtronic, ni somos responsables de ninguna actividad o transacción comerciales que realices en ellos. Tu uso del otro sitio está sujeto a las condiciones de uso y la declaración de privacidad de ese sitio.
Es posible que algunos de los productos en el otro sitio no estén aprobados en tu región o país.
Tu navegador está desactualizado
Con un navegador actualizado, tendrás una mejor experiencia en el sitio web de Medtronic. Actualizar mi navegador ahora.
La información de esta sección está dirigida exclusivamente al profesional sanitario residente en España facultado para prescribir o dispensar medicamentos, puesto que se requiere una formación especializada para su correcta interpretación.
Al aceptar, confirma que usted es un profesional sanitario.
How can we increase the number of patients being treated?
Can more stroke patients reach functional independence?
Find out how clinical and economic data can help you to optimize stroke care.
Comprehensive and flexible health economics solutions suitable for multiple stakeholders
Patient clinical benefit and cost implication estimates for hospitals and the health care system
Training and medical education programs
A team of experts,
ready to talk to you!
Medtronic has supported health economics studies* in 14 countries globally since 20151-16.
Argentina, Australia, Austria, Chile, Colombia, Italy, Poland, Portugal, Russia, Saudi Arabia, Singapore, Spain, United Kingdom, United States of America
of the studies have been published in peer reviewed journals or considered for reimbursement by HTA/Reimbursement authorities (Australia, Poland and Russia).
request a studyPartner with Medtronic and focus on what matters:
The urgent care you need to provide to give patients a better chance to recover from stroke.
de Andrés-Nogales, Fernando, et al. "Cost-effectiveness of mechanical thrombectomy using stent retriever after intravenous tissue plasminogen activator compared with intravenous tissue plasminogen activator alone in the treatment of acute ischaemic stroke due to large vessel occlusion in Spain." European Stroke Journal 2.3 (2017): 272-284.
Ruggeri, Matteo, et al. "Cost-effectiveness analysis of mechanical thrombectomy with stent retriever in the treatment of acute ischemic stroke in Italy." Journal of Medical Economics 21.9 (2018): 902-911.
Lobotesis, Kyriakos, et al. "Cost-effectiveness of stent-retriever thrombectomy in combination with IV t-PA compared with IV t-PA alone for acute ischemic stroke in the UK." Journal of Medical Economics 19.8 (2016): 785-794.
Ni, Weiyi, et al. "Lifetime quality of life and cost consequences of delays in endovascular treatment for acute ischaemic stroke: a cost-effectiveness analysis from a Singapore healthcare perspective." BMJ open 10.9 (2020): e036517.
Lenz-Alcayaga, Rony, et al. "Cost-utility analysis: Mechanical thrombectomy plus thrombolysis in ischemic stroke due to large vessel occlusion in the public sector in Chile." Medwave 21.3 (2021): e8152-e8152.
Arora, Nimita, et al. "Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective." Journal of medical economics 21.8 (2018): 799-809.
Al-Senani, Fahmi, et al. "A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change." International Journal of Stroke 14.8 (2019): 835-842.
Dombrovsky V. S., Ivakhnenko O. I., Avksentyeva M. V., Omelyanovskiy V. V., Musina N. Z. Efficacy and Efficiency of Mechanical Thromboextraction in Combination with Thrombolytic Therapy or as an Independent Method of Intravascular Treatment in Patients with Ischemic Stroke. Medical technologies. Evaluation and selection. 2018; 2 (32): 48–59.
Shireman, Theresa I., et al. "Cost-effectiveness of Solitaire stent retriever thrombectomy for acute ischemic stroke: results from the SWIFT-PRIME trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)." Stroke 48.2 (2017): 379-387.
Genovez, V., et al. "PCV37 Cost-Effectiveness Analysis of IV-TPA Followed By Mechanical Thrombectomy with Stent-Retriever versus IV-TPA alone in the treatment of Acute Ischemic Stroke due to Large Vessel Occlusion in Portugal." Value in Health 23 (2020): S493.
Pabon, B., et al. "P-018 Cost-effectiveness of endovascular stroke therapy. analysis from a Colombian healthcare perspective." (2019): A34-A35.
Pochopien M. et al. Cost-effectiveness analysis of mechanical thrombectomy in acute phase of ischemic stroke (AIS). Value in Health Volume 2017; 20, Issue 9, October–November 2017, Page A578.
Alcayaga, R. Lenz, et al. “PMD22: Budget Impact Analysis of the incorporation of mechanical thrombectomy with stent retrievers after thrombolysis in ischemic stroke with large vessel occlusion in the Chilean public sector.” Value in Health (2020), ISSN: 1098-3015, Vol: 23, Page: S192.
Lylyk, P., et al. "PND28 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Obras Sociales and Empresas De Medicina Prepaga in Argentina." Value in Health 24 (2021): S163-S164.
Lylyk, P., et al. "PND24 Cost-Utility of Mechanical Thrombectomy after Thrombolysis in Ischemic-Stroke due to Large Vessel Occlusion in Programa de Atencion medica Integral Pami in Argentina." Value in Health 24 (2021): S163.
Austria: Data on file.